Position in CELC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,219,051
New position
Shares Held
45,725
first reported quarter
Ownership
0.094%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Tidal Investments LLC holds $283,069,476 across 82 Biotechnology names. CELC ranks #13 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
92,081 | $41,117,849 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
39,652 | $30,636,720 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
57,927 | $19,166,306 | |
| 4 | EXEL |
Exelixis, Inc.
|
382,343 | $16,398,690 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
137,242 | $13,346,784 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
167,598 | $10,831,857 | |
| 7 | INSM |
INSMED Inc
|
61,776 | $10,101,611 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
129,601 | $9,624,170 |
All Filings in CELC
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,219,051 | 45,725 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||